Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16581022rdf:typepubmed:Citationlld:pubmed
pubmed-article:16581022lifeskim:mentionsumls-concept:C1333166lld:lifeskim
pubmed-article:16581022lifeskim:mentionsumls-concept:C1705705lld:lifeskim
pubmed-article:16581022lifeskim:mentionsumls-concept:C0007595lld:lifeskim
pubmed-article:16581022lifeskim:mentionsumls-concept:C1332813lld:lifeskim
pubmed-article:16581022lifeskim:mentionsumls-concept:C0600600lld:lifeskim
pubmed-article:16581022lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:16581022lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:16581022lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:16581022lifeskim:mentionsumls-concept:C0231449lld:lifeskim
pubmed-article:16581022pubmed:issue4lld:pubmed
pubmed-article:16581022pubmed:dateCreated2006-4-26lld:pubmed
pubmed-article:16581022pubmed:abstractTextWe have sequenced a 4.9kb clone (KLB22) which shares 99% sequence homology with the rabbit vasopressin-activated calcium mobilizing (VACM-1) protein. The 5' terminus sequence of KLB22 cDNA (nucleotides 1-1961) is continuous and overlapping with nucleotides 1226-3186 of the VACM-1 cDNA sequence. The 3'UTR of KLB22 cDNA extends beyond the 3'UTR of VACM-1 by 2999nt. KLB22 cDNA encodes a 497 amino acid protein, which putatively begins at Met 284 of the 780 amino acid VACM-1 protein. The in vitro translation of KLB22 cDNA yields a 59kDa protein. When expressed in cos-1 cells, the truncated VACM-1 protein localizes to the nucleus. KLB22 cDNA transfected cells show increased growth rates and increased levels of phosphorylated MAPK when compared to the vector or to VACM-1 cDNA transfected cells. Finally, in vivo, KLB22 protein expression is tissue specific and can be detected in kidney and in heart atrium. These results suggest that truncated VACM-1 cDNA (KLB22) increases cell proliferation through a MAPK pathway.lld:pubmed
pubmed-article:16581022pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16581022pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16581022pubmed:languageenglld:pubmed
pubmed-article:16581022pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16581022pubmed:citationSubsetIMlld:pubmed
pubmed-article:16581022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16581022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16581022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16581022pubmed:statusMEDLINElld:pubmed
pubmed-article:16581022pubmed:monthMaylld:pubmed
pubmed-article:16581022pubmed:issn0006-291Xlld:pubmed
pubmed-article:16581022pubmed:authorpubmed-author:LazdinsIIlld:pubmed
pubmed-article:16581022pubmed:authorpubmed-author:WilcoxRRlld:pubmed
pubmed-article:16581022pubmed:authorpubmed-author:ShearerRRlld:pubmed
pubmed-article:16581022pubmed:authorpubmed-author:ZhaiZZlld:pubmed
pubmed-article:16581022pubmed:authorpubmed-author:Burnatowska-H...lld:pubmed
pubmed-article:16581022pubmed:authorpubmed-author:SartorAshleig...lld:pubmed
pubmed-article:16581022pubmed:authorpubmed-author:KossorisJ BJBlld:pubmed
pubmed-article:16581022pubmed:authorpubmed-author:ZenebergA EAElld:pubmed
pubmed-article:16581022pubmed:issnTypePrintlld:pubmed
pubmed-article:16581022pubmed:day19lld:pubmed
pubmed-article:16581022pubmed:volume343lld:pubmed
pubmed-article:16581022pubmed:ownerNLMlld:pubmed
pubmed-article:16581022pubmed:authorsCompleteYlld:pubmed
pubmed-article:16581022pubmed:pagination1086-93lld:pubmed
pubmed-article:16581022pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:meshHeadingpubmed-meshheading:16581022...lld:pubmed
pubmed-article:16581022pubmed:year2006lld:pubmed
pubmed-article:16581022pubmed:articleTitleTruncated form of VACM-1/cul-5 with an extended 3' untranslated region stimulates cell growth via a MAPK-dependent pathway.lld:pubmed
pubmed-article:16581022pubmed:affiliationDepartments of Biology and Chemistry, Hope College, Holland, MI 49423, USA.lld:pubmed
pubmed-article:16581022pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16581022pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:16581022pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16581022pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed